Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypotension incidence during vasopressor weaning in septic shock
RBR-10smbw65Phase 4Recruiting
- Sponsor
- Hospital Nossa Senhora da Conceição
- Start
- May 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in septic shock comparing Initial noradrenaline reduction with Initial vasopressin reduction (2 arms). Primary endpoint: Incidence of hypotension within 24 hours after initiation of vasopressor reduction. Started May 2022; status: recruiting.
02
Drugs
norepinephrinevasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on RBR-10smbw65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10smbw65.